Explore
Search results
Since 2014, Aspen Ideas: Health has welcomed over 700 inspiring women leaders to our stages to share their bold approaches to better health. In honor of Women's History Month, we're taking a look back at some of the many highlights. From medical researchers and clinicians to entrepreneurs and activists, meet 12 change makers who are breaking barriers to reimagine a healthi...
Watch select daily livestreams and join the virtual #AspenIdeasHealth conversation from June 21-24!
Meet Nathan Chomilo, a 2023 Aspen Ideas: Health Fellow who’s incorporating community collaboration and racial equity into Minnesota’s Medicaid policy development.
From the "War on Cancer" to the "Cancer Moonshot", extraordinary progress continues to be made in the prevention, diagnosis, and treatment of cancer. Research is driving life-extending gene therapies, immunotherapies, and other targeted therapeutics forward. Otis Brawley of Johns Hopkins University explains the latest developments at the cutting-edge of cancer care.
Achieving vaccine equity requires authentically communicating with and listening to all communities. As healthcare leaders, we must go where the community is to hear their stories, comprehend their challenges and better understand how to overcome their hurdles. Presented by Novavax.
Monkeypox has now been declared a public health emergency in the US and a global emergency by the World Health Organization. What do we know about this virus and the current outbreak? During Aspen Ideas: Health 2022, Helen Branswell of STAT gave an explainer about monkeypox, highlighting five interesting things to know about the world's latest infectious disease concern.
With no end in sight to gridlock in Congress, federal courts will continue to have a significant impact on major health policy decisions. Katie Keith of Georgetown University Law Center helps us understand how litigation is shaping healthcare and public health in the United States– from access to preventative services to climate regulations.
Race, ethnicity, age, sex, environment, and other social determinants of health can all impact how different people respond to the same medicine or vaccine. This is why diversity and inclusivity at every stage of the medical research process are critical to learning about the safety and efficacy of potential treatments for all patients. Presented by Pfizer.
Hospitals and health systems have a critical role to play in turning health equity talk into action. Learn how the field is using strategic investments to drive innovative solutions forward. Presented by the American Hospital Association.
If you're fully vaccinated, are you protected from COVID-19? Will we need booster shots? What's the best way to keep children safe as they return to school? Infectious disease experts weigh in. Presented by Mount Sinai Health System.
Faced with the COVID-19 pandemic, the healthcare industry had to quickly adapt to confront the rapidly evolving challenges facing its patients, customers, and employees. Learn how three key decisions enabled Merck & Co. to accelerate innovation in 2020 and why these lessons will be critical to future success in addressing the most pressing healthcare challenges.
The coronavirus is mutating rapidly at the same time people around the world are getting vaccinated. Will the vaccines protect us from the variants?
This week marks one year since the first known COVID-19 death. And while the remarkable pace of vaccine development is widely praised, the lag in its distribution is concerning.
What would happen if genetic sequencing were standard care for undiagnosed diseases? And how can we ensure that the future of genomics benefits everyone, not just the one percent?
Ronald Klain was White House Ebola Response Coordinator from 2014 to 2015. This post has been updated and adopted from the author’s piece, Confronting the Pandemic Threat, published in Democracy Journal (No. 40, Spring 2016).